<?xml version="1.0" encoding="UTF-8"?>
<ref id="B108-vaccines-07-00053">
 <label>108.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Morrey</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Taro</surname>
    <given-names>B.S.</given-names>
   </name>
   <name>
    <surname>Siddharthan</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Smee</surname>
    <given-names>D.F.</given-names>
   </name>
   <name>
    <surname>Christensen</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Furuta</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents</article-title>
  <source>Antivir. Res.</source>
  <year>2008</year>
  <volume>80</volume>
  <fpage>377</fpage>
  <lpage>379</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2008.07.009</pub-id>
  <?supplied-pmid 18762216?>
  <pub-id pub-id-type="pmid">18762216</pub-id>
 </element-citation>
</ref>
